Three CNCR teams have been awarded a research grant under the ZonMw program “promising innovative therapies for Dementia”. With these grants, and in collaboration with their partners at the Amsterdam Institute of Molecular and Life Sciences (AIMMS) and the Alzheimer Center Amsterdam, the researchers will develop novel small-molecule interventions for Alzheimer’s disease.
Ruud Toonen and Claudia Persoon have joined an European collaborative project, subsidized by the dutch research council (ZonMw), focused on accelerating therapeutic development for rare neurodevelopmental disorders through drug repurposing strategies.
Seven partners from 6 countries including FGA and ESCO will develop new strategies using cellular assays based on IPSC-derived patient neurons and biomarker analyses.
The CNCR focuses on the mechanistic understanding of gene function in the context of cognitive function.
We provide Neuroscience research training programs at Bachelor, Master, PhD and Postdoc levels
Follow us on X
